🇺🇸 FDA
Patent

US 12091463

Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

granted A61KA61K38/00A61K38/17

Quick answer

US patent 12091463 (Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)) held by Orionis Biosciences, Inc expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K38/17, A61K38/212, A61K38/215